The consistency of this finding across multiple independent trials, different dose ranges, and various administration routes provides robust evidence that the peptide does not affect the growth hormone/IGF-1 axis
In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
International immunopharmacology , 170 , 116097
Its particularly effective at thickening individual strands and increasing overall density
Remove the plastic caps, wipe each rubber stopper with a fresh alcohol swab, and let the alcohol dry
It is more concentrated, meaning you draw less liquid per dose